about
Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood.Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug deliveryBiotin and biotinidase deficiencySodium dependent multivitamin transporter (SMVT): a potential target for drug deliveryBiotinLymphocyte propionyl-CoA carboxylase and its activation by biotin are sensitive indicators of marginal biotin deficiency in humansComparative analysis of ontogenic changes in renal and intestinal biotin transport in the ratLoss of taste responds to high-dose biotin treatment.Molecular characterization of the 5' regulatory region of rat sodium-dependent multivitamin transporter gene.Intestinal absorption of water-soluble vitamins in health and diseaseHigh-throughput immunoblotting identifies biotin-dependent signaling proteins in HepG2 hepatocarcinoma cells.Biotinylation of K12 in histone H4 decreases in response to DNA double-strand breaks in human JAr choriocarcinoma cellsPlasma concentration of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans.Marginal maternal biotin deficiency in CD-1 mice reduces fetal mass of biotin-dependent carboxylasesStructure-function activity of the human sodium-dependent multivitamin transporter: role of His¹¹⁵ and His²⁵⁴Marginal biotin deficiency during normal pregnancy.Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge.Lymphocyte propionyl-CoA carboxylase is an early and sensitive indicator of biotin deficiency in rats, but urinary excretion of 3-hydroxypropionic acid is notMarginal biotin deficiency is teratogenic in ICR mice.Determination of the biotin content of select foods using accurate and sensitive HPLC/avidin bindingUrinary excretion of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans.In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency.Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans.Marginal biotin deficiency can be induced experimentally in humans using a cost-effective outpatient design.Supplementation of biotin to sperm preparation medium increases the motility and longevity in cryopreserved human spermatozoaMeasurement of 3-hydroxyisovaleric acid in urine from marginally biotin-deficient humans by UPLC-MS/MSQuantitative measurement of urinary excretion of 3-hydroxyisovaleryl carnitine by LC-MS/MS as an indicator of biotin status in humansMarginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in miceClinical utility gene card for: Biotinidase deficiency-update 2015.The sodium/multivitamin transporter: a multipotent system with therapeutic implications.Scientific Opinion on Dietary Reference Values for biotinDietary intake of high-dose biotin inhibits spermatogenesis in young rats.
P2860
Q24538807-5090F607-1F45-4C63-BDE1-0AE9A7A4BB12Q24644494-6F7BD683-6857-4119-8946-9105FD4ED9EDQ24651550-A7DE5A69-24A3-4B8E-9705-0B540D2CBDCBQ26863420-EFC5DCCB-A238-43AA-BF54-3E368B84A802Q28026625-6BDDDD8B-BE50-4368-97D7-13412A966EE3Q28256559-CEE61642-EFDA-4829-8EAC-F098AEA8B289Q28570364-B93810C9-9D5A-45D0-9787-0379BF51A06EQ29036818-3F039BA4-2C13-490C-A4D7-C410742D70FFQ31919395-05350E94-6DEC-4409-A980-40C3377576DBQ33725184-B375CBE1-63FF-45A2-96C5-E9ED8B7EEC7BQ34016421-A1506FFA-05D5-4632-835C-47BD0AB1947AQ34093042-8DDDA659-A56C-4CDF-8F0E-0F0E00F4D3E3Q34308103-19745DF4-22C3-4A26-9B06-A95D7B38201BQ34313025-EEEE6112-FA29-4E45-8B25-A43172720B5FQ34501664-642C125C-5798-4AC8-8441-47F078F8CCC7Q34509478-812BB815-7CAC-43DE-856A-5B6B968D2955Q34536400-419BF198-094B-4526-A50D-3D0EBF994215Q34536406-6164E125-51EE-4897-99F4-1208C830AD7EQ34574116-654CC890-F16C-4749-A630-4FEB74AC99E0Q34575270-AB8FE66B-B1EC-4B3E-8323-A02439181D26Q34581941-E6086CB2-FC45-4E8B-A7C0-AC83EBF4806CQ34684215-68DF172C-2FA5-49AF-9ECA-9585C57CC20CQ35030494-93854368-4889-44E1-89EE-D80C2AA58A68Q35611000-80FE1813-6457-4413-983F-47985B98E692Q36106401-EDB38925-04F3-4A61-BF20-A894C323F835Q36772961-677045C6-FCD9-4D81-9F87-C2EB793E5CC2Q36813192-6589ED7A-2ADE-4193-B742-2275BCE95534Q37105796-A4F26AA1-013E-4BD2-867B-AD7315527E4AQ37351466-F4C53C17-BAE4-43BF-8D00-2EAA23F38FC7Q38394090-B1227146-2FBD-4961-B454-BDB93720A4D6Q47154242-65B5F154-7C3F-4A2C-ADAD-11CF40C79C6DQ48651192-4641A467-9555-433B-874D-7A2F2ADB3108
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Marginal biotin deficiency is teratogenic.
@ast
Marginal biotin deficiency is teratogenic.
@en
type
label
Marginal biotin deficiency is teratogenic.
@ast
Marginal biotin deficiency is teratogenic.
@en
prefLabel
Marginal biotin deficiency is teratogenic.
@ast
Marginal biotin deficiency is teratogenic.
@en
P2860
P1476
Marginal biotin deficiency is teratogenic.
@en
P2093
P2860
P356
10.1046/J.1525-1373.2000.22303.X
P577
2000-01-01T00:00:00Z